ManaMed announced that its portable deep vein thrombosis (DVT) prevention device, PlasmaFlow, is now available throughout the U.S.
The device, available through prescription, stimulates blood flow in the extremities through soft cuffs and is designed to be user-friendly with a 1-button operation and 10 hours of battery life. As patients are most vulnerable to getting a blood clot in the 14 days after surgery, the PlasmaFlow device is intended to be used during this period while the patient is recovering at the hospital or at home.
“Blood clots are a silent killer in the medical industry and we decided to up the fight against DVT related deaths,” said Trevor Theriot, CEO of ManaMed.
In addition to preventing DVT, PlasmaFlow can be used to enhance blood circulation, reduce post-operative pain and swelling, reduce wound healing time, aid in the treatment of stasis dermatitis, venous stasis ulcers, arterial and diabetic leg ulcers, chronic venous insufficiency, and reduce edema in the lower limbs.
The device is the first FDA-approved portable and tubeless sequential device with multiple pressure functions.
For more information visit Manamed.net.